Advertisement
Journal Home
Search for

Articles in Press

Return to articles in press list

Smooth muscle cells in porcine vein graft intimal hyperplasia are derived from the local vessel wall

Marc Jevona, Tahera I. Ansarib, Jonathan Fincha, Mustafa Zakkara, Paul C. Evansa, Sandra Shureya, Paul D. Sibbonsb, Phillip Hornicka, Dorian O. Haskarda, Anthony DorlingcCorresponding Author Information1email address

Received 20 January 2010; received in revised form 6 April 2010; accepted 19 April 2010. published online 01 June 2010.
Corrected Proof

Abstract 

Background

Accelerated intimal hyperplasia (IH) is an important cause of morbidity and mortality in patients with atherosclerotic vascular disease treated with bypass vein grafts. We used an interposition vein graft model to determine the source of neointimal cells in a clinically relevant large animal model.

Methods

Jugular vein segments from sex-mismatched, MHC-in-bred pigs were implanted into common carotid arteries bilaterally and harvested up to 8 weeks postsurgery for stereological, histological, and immunofluorescence analyses.

Results

Progressive IH lesions contained macrophages and smooth muscle cells (SMC). Fluorescent in situ hybridization following grafting of female veins into male arteries revealed that only ∼10% of the SMC were male, confirming that the majority of intimal SMC derived from the local vessel wall.

Conclusions

The majority of neointimal SMC in the IH seen after interposition vein grafting derive from the engrafted local vessel wall. These are the first results from a clinically relevant large animal model that confirm data from rodent models. They have implications for the utility of therapeutic stem cells in this type of intimal hyperplasia.

a Cardiovascular Sciences Unit, National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK

b Department of Surgical Research (TA, PS), Northwick Park Institute for Medical Research, Harrow, UK

c Department of Immunology, Imperial College London, Hammersmith Hospital, London, UK

Corresponding Author InformationCorresponding author. MRC Centre for Transplantation, King's College London, SE1 9RT London, UK. Tel.: +44 20 7188 5880; fax: +44 20 7188 5660.

 The authors declare no conflicts of interest.

1 Current address: MRC Centre for Transplantation, King's College London, Guy's Hospital, London SE1 9RT.

PII: S1054-8807(10)00062-1

doi:10.1016/j.carpath.2010.04.003

Advertisement